Pulsion Medical Systems SE (LTS:0NFX) 3-Year Revenue Growth Rate : 5.10% (As of Dec. 2022)

View and export this data going back to . Start your Free Trial

What is Pulsion Medical Systems SE 3-Year Revenue Growth Rate?

Pulsion Medical Systems SE's Revenue per Share for the six months ended in Dec. 2022 was €3.60.

During the past 12 months, Pulsion Medical Systems SE's average Revenue per Share Growth Rate was 6.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 5.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 4.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was -0.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Pulsion Medical Systems SE was 19.90% per year. The lowest was -8.00% per year. And the median was 4.80% per year.

Competitive Comparison of Pulsion Medical Systems SE's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Pulsion Medical Systems SE's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pulsion Medical Systems SE's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pulsion Medical Systems SE's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Pulsion Medical Systems SE's 3-Year Revenue Growth Rate falls into.

Pulsion Medical Systems SE 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Pulsion Medical Systems SE (LTS:0NFX) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Pulsion Medical Systems SE 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Pulsion Medical Systems SE's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Pulsion Medical Systems SE (LTS:0NFX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulsion Medical Systems SE (LTS:0NFX) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hans-Riedl-Street 17, Feldkirchen, DEU, 85622

Website

http://www.pulsion.com

Pulsion Medical Systems SE operates with its business units hemodynamic monitoring which is engaged in developing, manufacturing, and sale of systems used to monitor, diagnose, and manage physical parameters of patients in intensive care unit, and perfusion imaging which is engaged in developing, manufacturing, and sale of indocyanine green and complementary devices to visualize micro perfusion. The technology developed by the company for critical care are picco, proaqt, limon technology, and eirus technology.

Pulsion Medical Systems SE (LTS:0NFX) Headlines

No Headlines